On a single Friday this month, OpenAI shed three senior leaders, shut down a division it had publicly championed just months earlier, and quietly signaled that its ambitions for scientific AI are being absorbed into a coding application. All of this is happening while the company races toward an initial public offering at a reported $852 billion valuation.

The departures, confirmed on April 17, included Kevin Weil (former chief product officer turned head of OpenAI for Science), Srinivas Narayanan (chief technology officer for enterprise applications), and Bill Peebles (head of the Sora video product). Three senior departures in a single day would be notable at any large technology company. At OpenAI, where executive turnover has become something closer to a recurring event, it lands as the latest chapter in a leadership story that has been unraveling for over a year.

The Science Division Is Gone

OpenAI for Science was, until recently, one of the company's more publicly visible bets on the transformative potential of frontier AI. Weil joined OpenAI in June 2024 as chief product officer. By September 2025, he had pivoted internally to lead the science initiative, which was designed to attract academics and apply GPT-5's capabilities to physics, biology, and chemistry.

In January 2026, the team launched Prism, a dedicated web application built to give researchers a tailored AI workspace. MIT Technology Review profiled the initiative as active and ambitious, citing GPT-5.2's 92 percent score on the GPQA graduate-level science benchmark, a striking leap from GPT-4's 39 percent. Weil spoke at length in that profile about "epistemological humility" and self-fact-checking in AI models.

Three months later, the division no longer exists. Prism has been sunset. The roughly ten-person team has been folded into Codex, OpenAI's AI coding application, under Codex head Thibault Sottiaux. Weil announced his departure on social media: "Today is my last day at OpenAI, as OpenAI for Science is being decentralized into other research teams."

Codex Is Being Built Into 'Everything App'

The absorption of Prism's team into Codex is not an isolated decision. According to WIRED, OpenAI has "broader ambitions to turn Codex into an everything app." Rather than maintaining a portfolio of specialized tools for different domains (science, video, enterprise) the company is consolidating its agentic ambitions into a single product surface. Sora, the consumer video generation app, has already been discontinued. Prism is now gone. The pattern is clear.

The pivot has been building since at least March 2026, when Fidji Simo, OpenAI's chief executive of AGI deployment, told staff the company needed to simplify its product offerings. Simo herself is now on medical leave for what has been described as a serious neuroimmune condition (POTS). The strategy she outlined is being executed without her in the room.

The Leadership Drain Is Bigger Than This Week

Friday's triple exit does not exist in a vacuum. The scale of OpenAI's executive turnover over the past eighteen months is, by any measure, unusual for a company of its standing. Mira Murati, OpenAI's chief technology officer, departed in 2024. Greg Brockman, the company's co-founder and president, has been pulled back into an active role overseeing products after Simo's medical leave. Chief marketing officer Kate Rouch stepped away for cancer recovery. Chief operating officer Brad Lightcap moved into a loosely defined "special projects" role.

And Brockman, the same Brockman whose 2017 diary entry calling the nonprofit commitment "a lie" is the central piece of evidence in Musk v. Altman, will need to take the stand in Oakland this week. The trial begins Monday with jury selection.

What This Means for the IPO

OpenAI's S-1 filing, expected later this year, will need to disclose every one of these executive transitions as a material risk factor. Investors evaluating a $1 trillion IPO want to see deep, stable leadership. What they are getting is a company that lost three senior executives on the same day, dissolved a public-facing research initiative, has its head of AGI deployment on medical leave, and is staking its product strategy on a single application that did not exist as a standalone product two years ago.

The fate of Sora and Prism demonstrates that specialized applications at OpenAI carry a short shelf life when immediate commercial viability is not apparent. The science bet, which Weil described in interviews just three months ago as central to the company's mission, was disposable. The video bet, which OpenAI built up for years, was disposable. What is not disposable, apparently, is Codex. The company is making a single concentrated product bet at exactly the moment it goes public. That is a high-stakes wager. Investors will be watching whether it pays off, or whether 2027 brings another reorganization.